<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:g-core="http://base.google.com/ns/1.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel rdf:about="http://www.progressnp.com">
    <title>Progress in Neurology and Psychiatry EarlyView RSS Feed</title>
    <link>http://www.progressnp.com</link>
    <description>Progress in Neurology and Psychiatry EarlyView RSS Feed</description>
    <items>
      <rdf:Seq>
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1424341/Prions_Parkinsons_disease_and_the_search_for_a_new_generation_of_treatments.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1424343/Managing_bipolar_depression_a_therapeutic_challenge.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1424345/Use_of_Supervised_Community_Treatment_in_one_UK_healthcare_district.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1424347/Could_MDMA_be_useful_in_the_treatment_of_posttraumatic_stress_disorder.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1424349/International_League_Against_Epilepsy_UK_Chapter_meeting.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1424351/Digest.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1378453/The_UK_governments_new_mental_health_strategy_uncosted_and_unrealistic.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1378451/Prevalence_of_ADHD_in_four_general_adult_outpatient_clinics_in_North_East_Englan.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1378449/New_developments_in_the_detection_and_treatment_of_depression_in_cancer_settings.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1378447/From_teens_to_old_age_psychiatry_strives_to_help.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1378445/Neurodigest_latest_advances_in_neurology_for_primary_and_community_care.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1378443/Digest.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1312333/Cochrane_Database_of_Systematic_Reviews.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1312331/Care_pathway_clustering_issues_for_older_adult_mental_health_services.html" />
        <rdf:li resource="http://www.progressnp.com/details/journalArticle/1312329/Digest.html" />
      </rdf:Seq>
    </items>
  </channel>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1424341/Prions_Parkinsons_disease_and_the_search_for_a_new_generation_of_treatments.html">
    <title>Prions, Parkinson's disease and the search for a new generation of treatments</title>
    <link>http://www.progressnp.com/details/journalArticle/1424341/Prions_Parkinsons_disease_and_the_search_for_a_new_generation_of_treatments.html</link>
    <description>Abstract
      
         Recent research suggests that aggregates of cytosolic proteins such as α‐synuclein may spread in a manner similar to prions
            in certain neurodegenerative diseases. Mark Greener explains how drugs that can reduce formation or increase clearance of
            these proteins may represent new treatment strategies for Parkinson's disease. Copyright © 2011 John Wiley &amp;amp; Sons, Ltd.</description>
    <dc:date>2011-12-15T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1424343/Managing_bipolar_depression_a_therapeutic_challenge.html">
    <title>Managing bipolar depression: a therapeutic challenge?</title>
    <link>http://www.progressnp.com/details/journalArticle/1424343/Managing_bipolar_depression_a_therapeutic_challenge.html</link>
    <description>Abstract
      
         Most people with bipolar disorder first seek treatment for depressive rather than manic symptoms. However, effective management
            of bipolar depression remains a challenge. In this review, Celia Feetam highlights how bipolar depression differs from unipolar
            depression both in its characteristics and in the approach to its treatment. Copyright © 2011 John Wiley &amp;amp; Sons, Ltd.</description>
    <dc:date>2011-12-15T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1424345/Use_of_Supervised_Community_Treatment_in_one_UK_healthcare_district.html">
    <title>Use of Supervised Community Treatment in one UK healthcare district</title>
    <link>http://www.progressnp.com/details/journalArticle/1424345/Use_of_Supervised_Community_Treatment_in_one_UK_healthcare_district.html</link>
    <description>Abstract
      
         Supervised Community Treatment (SCT) was introduced in 2008 as part of the 2007 Mental Health Act Amendments, allowing Community
            Treatment Orders (CTOs) to be imposed in certain circumstances. Here, Drs Monnery and Belgamwar investigate whether the new
            CTOs have been applied within their Trust according to guidelines. They also examine the reasons behind the CTOs and their
            impact on admission to hospital. Copyright © 2011...</description>
    <dc:date>2011-12-15T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1424347/Could_MDMA_be_useful_in_the_treatment_of_posttraumatic_stress_disorder.html">
    <title>Could MDMA be useful in the treatment of post‐traumatic stress disorder?</title>
    <link>http://www.progressnp.com/details/journalArticle/1424347/Could_MDMA_be_useful_in_the_treatment_of_posttraumatic_stress_disorder.html</link>
    <description>Abstract
      
         In recent studies, 3,4‐methylenedioxymethylamphetamine (MDMA) has shown promise in the treatment of post‐traumatic stress
            disorder (PTSD) as an adjunct to post‐trauma psychological therapy. However, because of historical associations with its use
            as the recreational drug ecstasy, MDMA research remains a controversial subject. Dr Sessa discusses these controversies and
            describes a UK‐based MDMA/PTSD currently in development....</description>
    <dc:date>2011-12-15T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1424349/International_League_Against_Epilepsy_UK_Chapter_meeting.html">
    <title>International League Against Epilepsy UK Chapter meeting</title>
    <link>http://www.progressnp.com/details/journalArticle/1424349/International_League_Against_Epilepsy_UK_Chapter_meeting.html</link>
    <description>Abstract
      
         York Racecourse played host to the International League Against Epilepsy (ILAE) UK Chapter's 2011 annual scientific meeting
            in November, with over 300 delegates attending from all over the UK. Dr Joseph Anderson, Specialist Registrar and Clinical
            Teaching Fellow from the University Hospital of Wales, Cardiff, reports on some of the main highlights of the meeting. Copyright
            © 2011 John Wiley &amp;amp; Sons, Ltd.
         
     ...</description>
    <dc:date>2011-12-15T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1424351/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/1424351/Digest.html</link>
    <description>Abstract
      
         News
      
      
         Treating personality disorders
      
      
         The Department of Health has published its response to the consultation on a new pathway approach for the treatment and management
            of offenders with serious personality disorders (
            www.dh.gov.uk/health). It says ‘... it is clear ... that there is broad support for our plans and ... respondents agree that the National Offender
            Management...</description>
    <dc:date>2011-12-15T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1378453/The_UK_governments_new_mental_health_strategy_uncosted_and_unrealistic.html">
    <title>The UK government's new mental health strategy: uncosted and unrealistic</title>
    <link>http://www.progressnp.com/details/journalArticle/1378453/The_UK_governments_new_mental_health_strategy_uncosted_and_unrealistic.html</link>
    <description>Abstract
      
         Earlier this year, the first ever cross‐governmental mental health strategy was launched, laying out plans for the future
            of mental healthcare in England.1 The Government has recognised that mental health is not simply a Department of Health issue in isolation but that it affects
            every area of a person's life and impacts upon their ability to play an active role in society. The strategy, however, is
            woolly, uncosted and...</description>
    <dc:date>2011-10-21T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1378451/Prevalence_of_ADHD_in_four_general_adult_outpatient_clinics_in_North_East_Englan.html">
    <title>Prevalence of ADHD in four general adult outpatient clinics in North East England</title>
    <link>http://www.progressnp.com/details/journalArticle/1378451/Prevalence_of_ADHD_in_four_general_adult_outpatient_clinics_in_North_East_Englan.html</link>
    <description>Abstract
      
         Although it is now acknowledged that ADHD can persist into adulthood, its diagnosis and treatment remain rather patchy. In
            this study, the authors estimate the frequency of undiagnosed ADHD in four general adult psychiatry outpatient clinics in
            North East England, and investigate how effective two screening questionnaires are at identifying its presence. Copyright
            © 2011 Wiley Interface Ltd</description>
    <dc:date>2011-10-21T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1378449/New_developments_in_the_detection_and_treatment_of_depression_in_cancer_settings.html">
    <title>New developments in the detection and treatment of depression in cancer settings</title>
    <link>http://www.progressnp.com/details/journalArticle/1378449/New_developments_in_the_detection_and_treatment_of_depression_in_cancer_settings.html</link>
    <description>Abstract
      
         Depression is perhaps the most important mental health complication of cancer. While major depression is relatively uncommon
            and often missed, clinically significant mood disorders can occur in about 40 per cent of patients. In this review, Dr Mitchell
            discusses screening for depression in patients in cancer settings and outlines the current treatment options. Copyright ©
            2011 Wiley Interface Ltd</description>
    <dc:date>2011-10-21T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1378447/From_teens_to_old_age_psychiatry_strives_to_help.html">
    <title>From teens to old age: psychiatry strives to help</title>
    <link>http://www.progressnp.com/details/journalArticle/1378447/From_teens_to_old_age_psychiatry_strives_to_help.html</link>
    <description>Abstract
      
         Treatment challenges across the life course was the theme for the 10th Latest Advances in Psychiatry Symposium, held in London
            in March. Speakers addressed issues facing psychiatrists caring for patients from the teenage years right through to old age.
            Steve Titmarsh provides an overview of the key issues raised during the meeting. Copyright © 2011 Wiley Interface Ltd</description>
    <dc:date>2011-10-21T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1378445/Neurodigest_latest_advances_in_neurology_for_primary_and_community_care.html">
    <title>Neurodigest: latest advances in neurology for primary and community care</title>
    <link>http://www.progressnp.com/details/journalArticle/1378445/Neurodigest_latest_advances_in_neurology_for_primary_and_community_care.html</link>
    <description />
    <dc:date>2011-10-21T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1378443/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/1378443/Digest.html</link>
    <description>Abstract
      
         News
      
      
         NICE guideline on ADHD
      
      
         Consultation on the NICE guideline on ADHD (CG72) has now ended. The scheduled review will consider new evidence on diagnosis,
            management and the organisation of care emerging since the guideline was published in 2008. New clinical trials confirm current
            recommendations for the treatment of children, NICE says, and support the use of methylphenidate as firstline...</description>
    <dc:date>2011-10-21T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1312333/Cochrane_Database_of_Systematic_Reviews.html">
    <title>Cochrane Database of Systematic Reviews</title>
    <link>http://www.progressnp.com/details/journalArticle/1312333/Cochrane_Database_of_Systematic_Reviews.html</link>
    <description>Abstract
      
         Here, we bring readers extracts from the latest issues of The Cochrane Database of Systematic Reviews relevant to the fields
            of psychiatry and neurology. We feature a summary of the results, reviewers' conclusions, and implications for clinical practice
            and research, from selected new reviews featured in issues 6 and 7, 2011. For further information, visit 
            www.thecochranelibrary.com. Copyright © 2011 Wiley Interface Ltd
  ...</description>
    <dc:date>2011-08-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1312331/Care_pathway_clustering_issues_for_older_adult_mental_health_services.html">
    <title>Care pathway clustering: issues for older adult mental health services</title>
    <link>http://www.progressnp.com/details/journalArticle/1312331/Care_pathway_clustering_issues_for_older_adult_mental_health_services.html</link>
    <description>Abstract
      
         The imminent payment‐by‐results system for mental health in England means that Trusts need to reorganise delivery of care
            taking into account the new care pathway clusters. In this article, Dr Whelan and colleagues discuss the potential dilemmas
            and problems faced by the introduction of this system based on their own experience, with a particular focus on old age services.
            Copyright © 2011 Wiley Interface Ltd
         
    ...</description>
    <dc:date>2011-08-09T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://www.progressnp.com/details/journalArticle/1312329/Digest.html">
    <title>Digest</title>
    <link>http://www.progressnp.com/details/journalArticle/1312329/Digest.html</link>
    <description>Abstract
      
         News
      
      
         New models of mental health care for London
      
      
         London Health Programmes (
            www.londonhp.nhs.uk) has published new models of care for people experiencing a mental health crisis and for people with long‐term mental health
            conditions. Developed by service users, clinicians, commissioners and providers, Mental Health Models of Care for London aims to refocus existing services and staff rather...</description>
    <dc:date>2011-08-09T00:00:00Z</dc:date>
  </item>
</rdf:RDF>


